These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19440081)

  • 41. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome?
    Shen YC; Chen SJ; Lin CC; Chen CH
    Int Clin Psychopharmacol; 2007 Jul; 22(4):247-8. PubMed ID: 17519650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder.
    Reich DB; Zanarini MC; Bieri KA
    Int Clin Psychopharmacol; 2009 Sep; 24(5):270-5. PubMed ID: 19636254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
    Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
    J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
    Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression.
    Bowden CL; Singh V; Weisler R; Thompson P; Chang X; Quinones M; Mintz J
    Acta Psychiatr Scand; 2012 Nov; 126(5):342-50. PubMed ID: 22708645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
    Young LT; Joffe RT; Robb JC; MacQueen GM; Marriott M; Patelis-Siotis I
    Am J Psychiatry; 2000 Jan; 157(1):124-6. PubMed ID: 10618026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
    Bodkin JA; Siris SG; Bermanzohn PC; Hennen J; Cole JO
    Am J Psychiatry; 2005 Feb; 162(2):388-90. PubMed ID: 15677608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.
    Citrome L; Levine J; Allingham B
    Psychiatr Serv; 2000 May; 51(5):634-8. PubMed ID: 10783182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial.
    Guerdjikova AI; McElroy SL; Welge JA; Nelson E; Keck PE; Hudson JI
    Int Clin Psychopharmacol; 2009 May; 24(3):150-8. PubMed ID: 19357528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.
    Tritt K; Nickel C; Lahmann C; Leiberich PK; Rother WK; Loew TH; Nickel MK
    J Psychopharmacol; 2005 May; 19(3):287-91. PubMed ID: 15888514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.
    Ghaleiha A; Noorbala AA; Farnaghi F; Hajiazim M; Akhondzadeh S
    J Clin Psychopharmacol; 2010 Dec; 30(6):678-82. PubMed ID: 21105281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind trial of adjunctive allopurinol for schizophrenia.
    Dickerson FB; Stallings CR; Origoni AE; Sullens A; Khushalani S; Sandson N; Yolken RH
    Schizophr Res; 2009 Apr; 109(1-3):66-9. PubMed ID: 19195842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
    Fenton WS; Dickerson F; Boronow J; Hibbeln JR; Knable M
    Am J Psychiatry; 2001 Dec; 158(12):2071-4. PubMed ID: 11729030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.
    Zisook S; Kasckow JW; Golshan S; Fellows I; Solorzano E; Lehman D; Mohamed S; Jeste DV
    J Clin Psychiatry; 2009 Apr; 70(4):562-71. PubMed ID: 19192468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.
    Sommer IE; Begemann MJ; Temmerman A; Leucht S
    Schizophr Bull; 2012 Sep; 38(5):1003-11. PubMed ID: 21422107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
    Crawford MJ; Sanatinia R; Barrett B; Byford S; Cunningham G; Gakhal K; Lawrence-Smith G; Leeson V; Lemonsky F; Lykomitrou G; Montgomery A; Morriss R; Paton C; Tan W; Tyrer P; Reilly JG
    Trials; 2015 Jul; 16():308. PubMed ID: 26187496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of open-label lamotrigine as monotherapy and adjunctive therapy on the self-assessed cognitive function scores of patients with bipolar I disorder.
    Kaye NS; Graham J; Roberts J; Thompson T; Nanry K
    J Clin Psychopharmacol; 2007 Aug; 27(4):387-91. PubMed ID: 17679147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.